Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
NCT00277810
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
lecozotan SR (SRA-333)
Sponsor
Pfizer